Connect with us

Supplements

Mandatory Product Listing not included in omnibus spending bill

Published

on

[ad_1]

On December 7, Senator Dick Durbin, D-IL, called on his colleagues to support the inclusion of MPL language for dietary supplements in the Consolidated Appropriations Act of 2023 (H.R. 2617).

MPL would require dietary supplement manufacturers to notify the US Food and Drug Administration before bringing a product to market and to upload label information to a central database. 

The measure has split the dietary supplements industry, with some trade associations supporting MPL, and other opposing it, notably the American Herbal Products Association (AHPA) and the Natural Products Association (NPA). 

Just last month, AHPA sent a letter​ to Senate and House leadership requesting that no MPL language be added to any must-pass appropriations legislation to be considered during the lame duck session.

Daniel Fabricant, Ph.D. president and CEO of the Natural Products Association, called this week’s news, “a big win for consumers, for innovation, and for access to the healthy products that millions of Americans rely on and turned to during the height of the pandemic.

“We expected that industry critics would try to use the lame duck as another backdoor opportunity to jam this through and that’s exactly what happened,”​ said Dr Fabricant. “But thanks to NPA’s advocacy and the tens of thousands of individuals who took part in our grassroots campaign, that effort was rejected.”

Bipartisan support for an MPL?

On the other side, the Council for Responsible Nutrition has been a key champion for a mandatory listing, along with the Consumer Healthcare Products Association.

[ad_2]

Source link

Continue Reading

Supplements

Review calls for more studies on cinnamon and cognitive function

Published

on

[ad_1]

“This systematic review revealed that cinnamon and its components (eugenol, cinnamic acid, cinnamaldehyde, etc.) could affect memory and learning by decreasing amyloid plaque in the hippocampus and phosphorylation of tau-protein,” wrote researchers from Birjand University of Medical Sciences in Iran.

They attribute these brain-boosting benefits to cinnamon’s antioxidant, anti-inflammatory and anticholinesterase activity as well as neurotrophic effect, neural maintenance and insulin signaling improvement.

Cinnamon and its compounds

Cinnamon, from the inner bark of evergreen trees belonging to the genus Cinnamomum​, has been used in herbal medicine for centuries from China to Egypt as remedy for respiratory, digestive and menstruation issues. Today, as supplement, it is also suggested as support for healthy glycemic response and blood pressure.

“Cinnamon is proven to have antioxidant properties and reduce inflammation through different pathways, such as the NF-kB pathway and reducing reactive oxygen species (ROS),” the researchers noted. They attribute the antiproliferative, anti-inflammatory and antioxidant effects to compounds including eugenol, cinnamic acid, cinnamaldehyde, syringic acid, tannins and catechins.

Cinnamon also contains a small amount of choline, an essential nutrient for the brain that produces the acetylcholine neurotransmitters, which in turn play a critical role in regulating memory, mood, muscle control and other functions.

Indications of potential brain benefits

The research team conducted a systematic review of 40 eligible studies selected from a total of 1,605 collected from the Web of Science, Google scholar, PubMed and Scopus databases between 2011 and 2021. They include five in vitro​ studies, 33 in vivo​ studies in rats, mice and the common fruit fly, and two clinical trials in adolescents and pre-diabetic older adults. 

[ad_2]

Source link

Continue Reading

Supplements

Omega-3 supplements may be ‘most efficient’ way to support neonatal development, researchers say

Published

on

[ad_1]

It was also reported that after supplementing with DHA, levels of maternal DHA increased in erythrocyte phospholipids, serum, and breast milk.

“Our results confirmed usage of ‘omega’ dietary supplements as an efficient way of increasing the availability of EPA and DHA for infants,” ​stated Warsaw, Poland-based researchers in Nutrients​.

Essential Fats

There are established recommendations for the intake of essential fatty acids (EFA) and long-chain polyunsaturated fatty acids (LC PUFAs) for pregnant women, due to the recognised importance to the mother and child’s health. It has been found that these types of fats can increase gestational period and birth weight, as well as support the development of the child, in terms of the central nervous system and cognitive function.

“LC PUFA, especially DHA, plays a pivotal role in the development of the central nervous system, visual acuity, and cognitive functions. It depends on the involvement in maintaining membrane fluidity, impulse propagation, synaptic transmission, and functioning as a cytosolic signal-transducing factors for various gene expression during the critical period of brain development, which seems to be last trimester and first few months after birth,​” the researchers explain.

Due to the importance of these types of fatty acids, the present study sought to first analyse the frequency of consumption of fat sources as well as ‘omega’ supplements in pregnant patients. Secondly, the researchers measured the n-3 and n-6 serum FA contents at the time of labour of the pregnant women and their children using the GC-FID technique, to investigate subsequent nutritional status. The efficacy as well as the usefulness of the ‘omega’ supplements were then established.

[ad_2]

Source link

Continue Reading

Supplements

France to allow ‘probiotic’ on food supplements labels

Published

on

[ad_1]

The use of the term across Europe has been contentious since European authorities view it is an implied healthy claim since the official FAO/WHO definition denotes a health claim: “Live microorganisms which when administered in adequate amounts confer a health benefit on the host”.

Despite such a stance, more European countries are moving to allow the use of the term, notably Spain, Denmark, Italy, Greece, Poland, the Czech Republic, the Netherlands, and Bulgaria.

In France, the term “probiotic” may be used on food supplement labels together with the wording “contributes to the balance of the intestinal flora”​ so long as products meet certain conditions, such as a minimum number of living cells per daily dose, a position that is similar to the situation in Italy.

The announcement was welcomed by a number of stakeholders in the probiotics space, with Rosanna Pecere, executive director of IPA Europe, stating: IPA together with IPA Europe working diligently in the European environment for probiotics, are happy to see the softening position for the use of the term, and also happy with the added use of the claim.”

George Paraskevakos, IPA Global’s executive director, added: “This initiative links to all the probiotic on-going work globally and segues nicely into the continuation of the harmonization proposal of probiotic regulations at Codex Alimentarius which is set to resume later this year.

“The European market has shown the biggest jump in growth from an online sales perspective in 2022, outstripping other region growth rates by close to 5% as reported by Ewa Hudson’s Lumina Intelligence. This further emphasises the thirst for probiotic products from consumers in Europe, and further underscores the importance of the work which IPA EU and IPA are conducting not only in Europe but also globally to promote quality, safety, and probiotics that provide benefits.

[ad_2]

Source link

Continue Reading
Advertisement

Recent Posts

Advertisement

Sponsored Ads

TRENDING